Physiotherapy Program for Breast Cancer Women Following Surgery: A Pilot Clinical Trial

Sponsor
King Fahad Medical City (Other)
Overall Status
Completed
CT.gov ID
NCT04894565
Collaborator
(none)
23
1
1
29
0.8

Study Details

Study Description

Brief Summary

pilot study on physical therapy in women with breast cancer immediately following surgery

Condition or Disease Intervention/Treatment Phase
  • Procedure: rehabilitation
N/A

Detailed Description

A pilot, single-arm non-randomized clinical trial was conducted between the period September 2018 and June 2019 on a convenient sample of BC women. Primary study outcomes were pain, disabilities of the Arm, Shoulder, and Hand (DASH), handgrip strength, and quality of life (QoL). The secondary outcome was to assess the feasibility of this pilot study. All outcomes were recorded at three time- intervals (T0=day 1 post-operation), (T1=day 30), and (T1=day 90) under standardized conditions. The interventions were delivered by the physiotherapist early within 24 hours post-operatively, T1, and T2. In addition, home-based exercise was provided with written instructions during hospitalization with rehearsal sessions to ensure the patient's understanding and compliance

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Consecutive women with breast cancer who underwent breast cancer surgeryConsecutive women with breast cancer who underwent breast cancer surgery
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Home-based and Early Institutional Physiotherapy Program for Breast Cancer Women Following Surgery: A Pilot Clinical Trial
Actual Study Start Date :
Sep 1, 2018
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Feb 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention

effect of rehabilitation program in the intervention arm

Procedure: rehabilitation
physical therapy 24 hrs after surgery

Outcome Measures

Primary Outcome Measures

  1. Shoulder/Arm Pain [The measurements of the study outcomes took place at three time- intervals (T0=day 1 post-operation), (T1=day 30), and (T1=day 90).]

    Pain in the shoulder/arm was assessed using the visual analogue scale (VAS) with a scoring system of 0-10 (0 = no pain; 1-3; mild pain, 4-6; moderate pain, 7-10 severe pain)

  2. Shoulder mobility [The measurements of the study outcomes took place at three time- intervals (T0=day 1 post-operation), (T1=day 30), and (T1=day 90).]

    Shoulder mobility (flexion [0-180°], abduction [0-180°]) was measured by using a digital inclinometer under standardized conditions. Patients were maintained in a seated position for all movements to minimize compensatory movements of the trunk.

  3. Disabilities in daily life [The measurements of the study outcomes took place at three time- intervals (T0=day 1 post-operation), (T1=day 30), and (T1=day 90).]

    by using Quick DASH scale (Disabilities of the Arm, Shoulder, and Hand) questionnaire. The Quick DASH consists of 11 items that allow for cumulative and multiple assessments of a patient over time, and each item has 5 response options. According to the Quick DASH scale scoring system, the scale scores are calculated and ranging from 0 (no functional disability) to 100 (most severe disability)

  4. Handgrip strength [The measurements of the study outcomes took place at three time- intervals (T0=day 1 post-operation), (T1=day 30), and (T1=day 90).]

    measured while the patient stabilized in a seated position with the elbow in 90 degrees of flexion and squeezes three times the dynamometer with each hand.

  5. Quality of Life (QoL) [The measurements of the study outcomes took place at three time- intervals (T0=day 1 post-operation), (T1=day 30), and (T1=day 90).]

    Patients' QoL was assessed by using the Functional Assessment of Cancer Therapy-General (FACT-G) scale. FACT-G (version-4) is a validated, self-reported multi-dimensional, 27-items questionnaire measuring QoL for breast cancer patients with 1 4-points Likert scale (0-108). The FACT-G comprises of 4-subscales: Physical Well-being (PWB: 7-items; score range 0 to 28), Social Well-being (SWB: 7-items; score range 0 to 28), Emotional Well-being (EWB: 6-items; score range 0 to 24), Functional Well-being (FWB: 7-items; score range 0 to 28)

Secondary Outcome Measures

  1. Establishing firmly study feasibility [3 months]

    Assess for clinical effect size (ES) worth investigation, sample recruitment strategy, adherence to study protocol, and adverse events in preparation to conduct a larger definitive study.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • women with breast cancer who require surgical resection
Exclusion Criteria:
  • in ability to undergo 3 months of physical therapy program

Contacts and Locations

Locations

Site City State Country Postal Code
1 KFMC Riyadh Saudi Arabia

Sponsors and Collaborators

  • King Fahad Medical City

Investigators

  • Principal Investigator: Noura Binsaad, MD, Consultant

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hussam Sakkijha, Principal Investigator, King Fahad Medical City
ClinicalTrials.gov Identifier:
NCT04894565
Other Study ID Numbers:
  • 18-115
First Posted:
May 20, 2021
Last Update Posted:
May 24, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 24, 2021